Imagine a smart, injectable gel made from potato waste that can rebuild jawbones. It acts like a 3D-printed scaffold that changes shape or properties over time to help the body heal. This helps cancer survivors whose bones were damaged by the very drugs used to save them.
Cancer survivors using bone-targeting agents often suffer from MRONJ, a severe jawbone destruction that leads to infection and malnutrition. Current treatments rely on long-term antibiotics, which increase the risk of antimicrobial resistance.
A sustainable, antimicrobial 4D hydrogel scaffold made from potato waste that can be injected or printed to regenerate bone tissue.
If you are a biomaterials manufacturer dealing with the need for biocompatible scaffolds — this project developed a 4D material derived from potato waste that promotes bone regeneration. It allows for non-invasive surgical procedures and is designed to meet medical standards.
If you are an oncology drug developer dealing with the side effects of bone-targeting agents — this project developed a treatment strategy for MRONJ. It provides a way to mitigate the bone destruction affecting approximately 12,000 people in Europe and the UK.
If you are a food processing company dealing with potato waste side streams — this project developed a sustainable manufacturing process to turn that waste into high-value medical nanoparticles. This transforms a waste stream into a climate-neutral medical product.
Based on available project data, specific pricing or cost analysis is not provided, though the project emphasizes using low-cost potato waste side streams.
Yes, the project objective explicitly mentions developing a sustainable manufacturing process to enable production scale-up using climate-neutral methods.
Based on available project data, the specific licensing terms are not listed, but the project aims to support European industries in developing new markets and products.
The project runs from 2025-06-01 to 2029-05-31, with the goal of being ready for Phase I clinical trials by the end of the project.
The material is designed to be injectable or printable as a scaffold, specifically for use in non-invasive surgical procedures.
The consortium is heavily research-driven with 9 universities and 5 research institutes, but it maintains a practical edge with 3 SMEs and 3 industrial partners (17% industry ratio). Spanning 12 countries, this structure suggests a strong academic foundation for the 4D material development with a focused group of SMEs to handle the transition to medical manufacturing standards.
Contact the University of Liverpool regarding the GreenNanoBone project
Contact SciTransfer for detailed partnership matchmaking with the GreenNanoBone consortium.
